← Back to Search

MBAT course for Cognitive Impairment

N/A
Waitlist Available
Led By Amishi Jha
Research Sponsored by University of Miami
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline to week 6 and week 11.
Awards & highlights

Study Summary

This trial will investigate whether mindfulness training can help improve cognitive, affective, and social readiness in soldiers, as well as help them better retain their position in the Army.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline to week 6 and week 11.
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to week 6 and week 11. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Attentional Performance
Change in Cognitive Failures
Change in Working Memory Performance
Secondary outcome measures
Change in Decentering
Change in Mind Wandering
Change in Negative Affect
+3 more
Other outcome measures
Applied Mindfulness Process Scale
Change in Perspective Taking
Change in Post-Traumatic Stress Disorder (PTSD) symptomatology

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Mindfulness training (MT) groupExperimental Treatment1 Intervention
Receives 4 weeks of mindfulness training followed by a testing session.
Group II: No-training control (NTC) groupActive Control1 Intervention
Receives 4 weeks of no mindfulness training followed by a testing session.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
MBAT course
2022
N/A
~250

Find a Location

Who is running the clinical trial?

University of MiamiLead Sponsor
902 Previous Clinical Trials
409,831 Total Patients Enrolled
United States Department of DefenseFED
865 Previous Clinical Trials
327,454 Total Patients Enrolled
Amishi JhaPrincipal InvestigatorUniversity of Miami
1 Previous Clinical Trials
300 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are applicants aged 25 or above eligible to join this experiment?

"The age range for potential participants in this medical trial begins at 18 and ends at 65."

Answered by AI

Who meets the qualifications to participate in this medical experiment?

"This clinical trial, which is open to 300 participants aged 18-65 with cognitive changes, seeks potential candidates for recruitment."

Answered by AI

What is the main aim of this clinical experiment?

"This 6-week clinical trial aims to measure a Change in Working Memory Performance. The secondary outcomes measured will be the change in Emotion Regulation (assessed using the Difficulties in Emotion Regulation Scale, ranging from 18 - 90 points), Positive Affect (measured by the Positive and Negative Affect Schedule, with scores between 5 - 25) and Negative Affect (also assessed through PANAS, scoring between 5 - 25)."

Answered by AI

Are there any openings still available for participation in this experiment?

"According to clinicaltrials.gov, this specific medical study is no longer recruiting patients. Initially posted on March 16th 2022 and last modified October 18th 2022, the trial does not presently have any vacancies; however, there are 52 other studies open for applications."

Answered by AI
~79 spots leftby Apr 2025